BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22487909)

  • 1. Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry.
    Blana A; Robertson CN; Brown SC; Chaussy C; Crouzet S; Gelet A; Conti GN; Ganzer R; Pasticier G; Thuroff S; Ward JF
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):256-9. PubMed ID: 22487909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
    Pfeiffer D; Berger J; Gross AJ
    BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
    Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Whelan K; Shayegan B; Orovan WL
    BJU Int; 2012 Oct; 110(8):1142-8. PubMed ID: 22372721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
    Thüroff S; Chaussy C
    J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
    Ganzer R; Robertson CN; Ward JF; Brown SC; Conti GN; Murat FJ; Pasticier G; Rebillard X; Thuroff S; Wieland WF; Blana A
    BJU Int; 2011 Oct; 108(8 Pt 2):E196-201. PubMed ID: 21332907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes.
    Komura K; Inamoto T; Masuda H; Watsuji T; Azuma H
    Acta Biomed; 2012 Dec; 83(3):189-96. PubMed ID: 23762994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
    Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
    BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
    Inoue Y; Goto K; Hayashi T; Hayashi M
    Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.
    Blana A; Murat FJ; Walter B; Thuroff S; Wieland WF; Chaussy C; Gelet A
    Eur Urol; 2008 Jun; 53(6):1194-201. PubMed ID: 17997026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
    Poissonnier L; Gelet A; Chapelon JY; Bouvier R; Rouviere O; Pangaud C; Lyonnet D; Dubernard JM
    Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
    BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
    Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
    Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
    Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
    Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of prostate cancer by transrectal HIFU in 227 patients.
    Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
    Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study.
    Uchida T; Baba S; Irie A; Soh S; Masumori N; Tsukamoto T; Nakatsu H; Fujimoto H; Kakizoe T; Ueda T; Ichikawa T; Ohta N; Kitamura T; Sumitomo M; Hayakawa M; Aoyagi T; Tachibana M; Ikeda R; Suzuki K; Tsuru N; Suzuki K; Ozono S; Fujimoto K; Hirao Y; Monden K; Nasu Y; Kumon H; Nishi K; Ueda S; Koga H; Naitoh S
    Hinyokika Kiyo; 2005 Oct; 51(10):651-8. PubMed ID: 16285617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
    Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
    BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of localized prostate cancer using high-intensity focused ultrasound.
    Uchida T; Ohkusa H; Nagata Y; Hyodo T; Satoh T; Irie A
    BJU Int; 2006 Jan; 97(1):56-61. PubMed ID: 16336329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.